Skip to main content

You must have JavaScript enabled in order to access this part of the site. Please enable JavaScript and then reload this page in order to continue.

Rituximab Procedure Code J9312 to Be a Benefit of the CSHCN Services Program

Last updated on

Beginning January 27, 2022, for dates of service on or after January 1, 2022, procedure code J9312 Rituximab will be a benefit of the Children with Special Health Care Needs (CSHCN) Services Program for the treatment of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and granulomatosis with polyangiitis.

Any affected claims that are identified will be reprocessed. Providers are not required to appeal the claims unless they are denied for additional reasons after the claims reprocessing is completed.

For more information, call the TMHP-CSHCN Services Program Contact Center at 800-568-2413.